Drug Research Services, Inc.

Metairie, Louisiana 70006

0 studies enrolling now · 8 studies all time

What they study most

Crohn's Disease, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Disease, Inflammatory Bowel Disease, Ulcerative Colitis

Studies at this site

• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis — Completed
• Remission in Subjects With Crohn's Disease, 1 Year Phase — Completed
• Remission in Subjects With Crohn's Disease, Open Label Extension — Completed
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis — Completed
• Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). — Completed
• Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease — Completed
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed
• A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed